PT  - JOURNAL ARTICLE
AU  - Duchowny, Kate A.
AU  - Mau, Theresa
AU  - Diaz-Ramierz, L. Grisell
AU  - Lui, Li-Yung
AU  - Marcinek, David J.
AU  - Toledo, Frederico G. S.
AU  - Cawthon, Peggy M.
AU  - Hepple, Russell T.
AU  - Kramer, Philip A.
AU  - Newman, Anne B.
AU  - Kritchevsky, Stephen B.
AU  - Cummings, Steven R.
AU  - Coen, Paul M.
AU  - Molina, Anthony J. A.
TI  - Childhood adverse life events and skeletal muscle mitochondrial function
AID  - 10.1101/2023.11.07.23298177
DP  - 2023 Jan 01
TA  - medRxiv
PG  - 2023.11.07.23298177
4099  - http://medrxiv.org/content/early/2023/11/08/2023.11.07.23298177.short
4100  - http://medrxiv.org/content/early/2023/11/08/2023.11.07.23298177.full
AB  - Social stress experienced in childhood is associated with adverse health later in life. Mitochondrial function has been implicated as a mechanism for how stressful life events “get under the skin” to influence physical wellbeing. Using data from the Study of Muscle, Mobility and Aging (n=879, 59% women), linear models examined whether adverse childhood events (i.e., physical abuse) were associated with two measures of skeletal muscle mitochondrial energetics in older adults: (1) maximal adenosine triphosphate production (ATPmax) and (2) maximal state 3 respiration (Max OXPHOS). Forty-five percent of the sample reported experiencing 1+ adverse childhood event. After adjustment, each additional event was associated with -0.07 SD (95% CI= - 0.12, -0.01) lower ATPmax. No association was observed with Max OXPHOS. Adverse childhood events are associated with lower ATP production in later life. Findings indicate that mitochondrial function may be a mechanism in understanding how early social stress influences health in later life.Competing Interest StatementThe authors have declared no competing interest.Funding StatementFunding: The Study of Muscle, Mobility and Aging is supported by funding from the National Institute on Aging, grant number AG059416. Study infrastructure support was funded in part by NIA Claude D. Pepper Older American Independence Centers at University of Pittsburgh (P30AG024827) and Wake Forest University (P30AG021332) and the Clinical and Translational Science Institutes, funded by the National Center for Advancing Translational Science, at Wake Forest University (UL1 0TR001420). This study was also partially funded by the U.S. National Institutes of Health, National Institute on Aging R00AG066846 (KAD)Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:All SOMMA participants provided written informed consent, and the study was approved by the WIRB-Copernicus Group (WCG IRB) (20180764).I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.YesAll data produced in the present study are available upon reasonable request to the authors